FDA Authorizes Four New ENDS Pods with Age-Restriction Technology
The FDA has approved marketing of four Glas e-cigarette pods featuring advanced age verification to prevent youth use while expanding adult access to non-tobacco…
Category
Health & Public Health
Health & Public Health covers major developments in healthcare, medicine, medical research, public health, food safety, health policy, insurance, drug safety, and safety issues affecting readers in the United States and around the world. This section focuses on clear, factual reporting from credible sources, including government health agencies, medical research institutions, public health organizations, and trusted news outlets. Coverage may include FDA updates, NIH research, disease prevention, healthcare costs, medication safety, public health alerts, hospital systems, and policy decisions that affect patients and communities.
Elisabeth Armstrong Named NIH Chief of Staff
Elisabeth Armstrong joins the NIH Office of the Director to oversee operations and advise leadership with broad public and private sector experience
Suspected Hantavirus Outbreak Strands Passengers on Cruise Ship
A suspected hantavirus outbreak aboard the MV Hondius has infected about 150 people and caused at least three deaths, prompting ongoing investigations and quarantine…
FDA Reports Low Contaminant Levels in Largest U.S. Infant Formula Study
The FDA’s comprehensive testing of over 300 infant formula samples found low contaminant levels, affirming the safety of the U.S. formula supply while promising…
FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List
The FDA proposes to exclude three diabetes-related drugs from the list of bulk substances allowed for compounding by outsourcing facilities due to lack of…
FDA Approves Auvelity for Agitation in Alzheimer’s Dementia
The FDA authorized Auvelity as the first non-antipsychotic treatment for agitation symptoms in adults with Alzheimer’s disease dementia
FDA Approves Expanded Access for Pancreatic Cancer Drug Daraxonrasib
The FDA has authorized expanded access use of the experimental drug daraxonrasib for patients with metastatic pancreatic cancer who have exhausted other treatments
NIH Awards $150,000 to Teams Innovating Nutrition Research in Autoimmune Disease
Fifteen scientific teams received $10,000 each from the NIH for innovative approaches linking diet and nutrition to autoimmune disease onset and management